このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Procter & Gamble Hygiene and Health Care 将来の成長

Future 基準チェック /36

Procter & Gamble Hygiene and Health Care利益と収益がそれぞれ年間13.5%と9.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に89.7% 12.9%なると予測されています。

主要情報

13.5%

収益成長率

12.9%

EPS成長率

Personal Products 収益成長	17.1%
収益成長率	9.7%
将来の株主資本利益率	89.7%
アナリストカバレッジ	Low
最終更新日	02 May 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BSE:500459 - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2026	51,152	10,103	10,608	N/A	2
6/30/2025	46,367	8,919	9,583	N/A	2
6/30/2024	42,315	7,883	4,824	N/A	1
3/31/2024	41,265	7,452	N/A	N/A	N/A
12/31/2023	40,074	7,559	6,647	7,070	N/A
9/30/2023	40,114	7,344	N/A	N/A	N/A
6/30/2023	39,179	6,781	7,813	8,258	N/A
3/31/2023	38,418	5,695	N/A	N/A	N/A
12/31/2022	39,319	5,073	4,402	4,981	N/A
9/30/2022	38,875	5,119	N/A	N/A	N/A
6/30/2022	39,009	5,758	5,233	5,731	N/A
3/31/2022	39,111	5,822	N/A	N/A	N/A
12/31/2021	36,975	5,777	7,399	7,698	N/A
9/30/2021	36,230	6,162	N/A	N/A	N/A
6/30/2021	35,741	6,518	8,315	8,631	N/A
3/31/2021	34,221	6,720	N/A	N/A	N/A
12/31/2020	33,185	6,648	8,119	8,679	N/A
9/30/2020	31,593	5,501	N/A	N/A	N/A
6/30/2020	30,020	4,331	4,227	4,738	N/A
3/31/2020	30,048	4,247	N/A	N/A	N/A
12/31/2019	30,480	4,237	3,257	3,532	N/A
9/30/2019	30,068	4,119	N/A	N/A	N/A
6/30/2019	29,469	4,191	3,969	4,130	N/A
3/31/2019	28,339	4,029	N/A	N/A	N/A
12/31/2018	27,034	3,960	N/A	N/A	N/A
9/30/2018	25,895	4,031	N/A	N/A	N/A
6/30/2018	24,553	3,746	3,774	4,155	N/A
3/31/2018	24,335	4,081	N/A	N/A	N/A
12/31/2017	24,385	4,245	N/A	N/A	N/A
9/30/2017	23,776	4,439	N/A	N/A	N/A
6/30/2017	23,204	4,327	N/A	4,453	N/A
3/31/2017	25,574	4,647	N/A	N/A	N/A
12/31/2016	25,277	4,622	N/A	N/A	N/A
9/30/2016	25,433	4,581	N/A	N/A	N/A
6/30/2016	22,754	4,225	N/A	3,525	N/A
3/31/2016	24,823	4,209	N/A	N/A	N/A
12/31/2015	24,233	4,105	N/A	N/A	N/A
9/30/2015	23,543	3,544	N/A	N/A	N/A
6/30/2015	23,323	3,461	N/A	4,256	N/A
3/31/2015	22,601	3,290	N/A	N/A	N/A
12/31/2014	22,056	3,228	N/A	N/A	N/A
9/30/2014	21,321	3,087	N/A	N/A	N/A
6/30/2014	20,486	3,020	N/A	3,352	N/A
3/31/2014	19,886	2,640	N/A	N/A	N/A
12/31/2013	19,049	2,353	N/A	N/A	N/A
9/30/2013	18,048	2,127	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 500459の予測収益成長率 (年間13.5% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: 500459の収益 ( 13.5% ) Indian市場 ( 16% ) よりも低い成長が予測されています。

高成長収益: 500459の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 500459の収益 ( 9.7% ) Indian市場 ( 9.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: 500459の収益 ( 9.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 500459の自己資本利益率は、3年後には非常に高くなると予測されています ( 89.7 %)。

Procter & Gamble Hygiene and Health Care 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target increased by 9.2% to ₹16,940

Price target decreased to ₹14,250

Price target decreased to ₹14,250

Price target decreased to ₹15,850

Price target increased to ₹17,450

Price target increased to ₹15,900

Recent updates

Procter & Gamble Hygiene and Health Care Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

P&G Hygiene and Health Care Announces Chief Financial Officer Changes

P&G Hygiene and Health Care Announces Chief Financial Officer Changes

Third quarter 2024 earnings released: EPS: ₹47.56 (vs ₹50.84 in 3Q 2023)

Procter & Gamble Hygiene and Health Care Limited to Report Q3, 2024 Results on Apr 30, 2024

Less than half of directors are independent

Second quarter 2024 earnings released: EPS: ₹70.51 (vs ₹63.91 in 2Q 2023)

Procter & Gamble Hygiene and Health Care Limited Announces Resignation of Karthik Natarajan as Non- Executive Director, Effective from Close of Business Hours of March 31, 2024

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2024 Results on Jan 31, 2024

Upcoming dividend of ₹105 per share at 1.0% yield

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 24, 2023

First quarter 2024 earnings released: EPS: ₹64.91 (vs ₹47.57 in 1Q 2023)

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2024 Results on Oct 30, 2023

Price target increased by 9.2% to ₹16,940

Procter & Gamble Hygiene and Health Care Limited Announces Change in Management

Full year 2023 earnings released: EPS: ₹209 (vs ₹177 in FY 2022)

Procter & Gamble Hygiene and Health Care Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Third quarter 2023 earnings released: EPS: ₹50.84 (vs ₹31.68 in 3Q 2022)

Procter & Gamble Hygiene and Health Care Limited Approves Dividend for the Financial Year 2022-23, Payable on or Before February 28, 2023

Second quarter 2023 earnings released: EPS: ₹63.91 (vs ₹65.33 in 2Q 2022)

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2023 Results on Jan 31, 2023

Price target decreased to ₹14,250

Less than half of directors are independent

Price target decreased to ₹14,250

Upcoming dividend of ₹65.00 per share

Full year 2022 earnings released: EPS: ₹177 (vs ₹201 in FY 2021)

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2023 Results on Nov 02, 2022

Procter & Gamble Hygiene and Health Care Limited, Annual General Meeting, Nov 15, 2022

Procter & Gamble Hygiene and Health Care Limited Recommends Final Dividend for the Financial Year Ended June 30, 2022, Payable Between November 15, 2022 to December 13, 2022

Price target decreased to ₹15,850

Third quarter 2022 earnings released: EPS: ₹31.68 (vs ₹30.29 in 3Q 2021)

Less than half of directors are independent

Procter & Gamble Announces Appointment of LV Vaidyanathan as Chief Executive Officer for its Operations in India from July 1, 2022 Replacing Madhusudan Gopalan

Procter & Gamble Hygiene and Health Care Limited to Report Q3, 2022 Results on Apr 28, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Procter & Gamble Hygiene and Health Care Limited Declares Interim Dividend for the Financial Year 2022, Payable on or Before February 28, 2022

Price target increased to ₹17,450

Upcoming dividend of ₹80.00 per share

Full year 2021 earnings released: EPS ₹201 (vs ₹133 in FY 2020)

Company Secretary & Compliance Officer Flavia Machado has left the company

Full year 2021 earnings released: EPS ₹201 (vs ₹133 in FY 2020)

Third quarter 2021 earnings released: EPS ₹30.29 (vs ₹28.07 in 3Q 2020)

Procter & Gamble Hygiene and Health Care Limited Declares Special Interim Dividend for the Financial Year 2021, Payable Between May 25, 2021 to June 2, 2021

Price target increased to ₹15,900

Second quarter 2021 earnings released: EPS ₹77.21 (vs ₹41.88 in 2Q 2020)

New 90-day high: ₹12,289

Procter & Gamble Hygiene and Health Care Limited to Report Q2, 2021 Results on Feb 03, 2021

New 90-day high: ₹11,409

First quarter 2021 earnings released: EPS ₹78.21

Price target raised to ₹11,700

Full year 2020 earnings released: EPS ₹133

Procter & Gamble Hygiene and Health Care Limited to Report Q1, 2021 Results on Nov 10, 2020

P&G-owned skincare brand Olay Teams Up with Shopee to Empower Digital-Savvy Millennials in Southeast Asia to #AdultFearlessly

New 90-day low: ₹9,862

Procter & Gamble Hygiene and Health Care Limited(BSE:500459) dropped from S&P Global BMI Index

Full year earnings released - EPS ₹133

Procter & Gamble Hygiene and Health Care Limited to Report Fiscal Year 2020 Results on Aug 25, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘